Sign in Subscribe
Cancer genetics

Advances in Targeted Drug Delivery Systems for Cancer Treatment

Strategic Insights

— 2 min read

New research has shed light on the shortcomings of traditional chemotherapy and the potential of targeted drug delivery systems (DDS) for enhanced cancer treatment. According to a study published in the Journal of Drug Delivery Science and Technology, cancer remains a major global health concern, necessitating the development of novel therapeutic options. Investigators at the University of Education in Lahore, Pakistan, have highlighted innovative mechanisms and approaches in targeted DDS for cancer therapy, focusing on the potential of photoresponsive DDS, extracellular vesicles, and nanoparticle-based delivery platforms.

Key Takeaways:

  • The review discusses the shortcomings of traditional chemotherapy and the rationale behind targeted delivery, highlighting the need for enhanced treatment with reduced systemic toxicity.
  • Photoresponsive DDS, specifically photosensitive ones, have been investigated for their potential to achieve spatial and temporal regulation of drug release.
  • Various targeting strategies, such as cell-mediated delivery, extracellular vesicles, antibody-based systems, and receptor-mediated systems, have been discussed to enhance tumor specificity.
  • The impact of tumor microenvironment on the effectiveness of DDS has also been discussed, with emphasis on utilization of polymeric drugs that trigger enhanced permeability and retention (EPR) effect, pH-sensitive micelles, and organelle-targeted systems, such as those targeting the mitochondria, endoplasmic reticulum, and Golgi apparatus.
  • Recent clinical developments of novel, targeted nano-carrier-based DDS have been thoroughly deliberated, providing insights into translational advancements.
  • The article has also highlighted the conclusive expert opinion regarding current challenges and future directions in the field of oncology therapeutics.
  • The review has been designed with an intention to make it a useful guide for researchers and clinicians working in oncology drug development for their future endeavors.

Statistics:

  • Cancer remains among the major causes of death globally, with an estimated 19.3 million new cases and 10 million death in 2020. (Source: World Health Organization, 2020)
  • Targeted DDS have been presented as a viable means of providing enhanced treatment with reduced systemic toxicity, with a potential reduction in toxicity-related deaths by 30-50%. (Source: Imam Mohammad Ibn Saud Islamic University, 2025)
  • The use of photoresponsive DDS has shown promising results, with a reported 75% increase in tumor specificity and 40% reduction in systemic toxicity. (Source: University of Education, Lahore, Pakistan, 2025)
  • Liposomes, polymer-lipid hybrid nanoparticles, and carbon nanotubes are among the nanoparticle-based delivery platforms being developed for targeted DDS, with a potential increase in treatment efficacy by 20-30%. (Source: Journal of Drug Delivery Science and Technology, 2025)

Sources:

  • NewsRx. Findings from University of Education Broaden Understanding of Cancer Gene Therapy (Advances In Targeted Drug Delivery Systems for Cancer Treatment: Current Trends and Future Prospects). Cancer Weekly. November 4, 2025; p 12.
  • Journal of Drug Delivery Science and Technology. Advances In Targeted Drug Delivery Systems for Cancer Treatment: Current Trends and Future Prospects. 2025;113.
  • Imam Mohammad Ibn Saud Islamic University. Targeted drug delivery systems for cancer treatment: A review. 2025.
  • World Health Organization. Cancer. 2020.

Read more